StockData
Alector, Inc. logo

Alector, Inc. (ALEC) stock

ALECNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$2.30−0.27 (-10.51%)

Close on Nov 19, 2026Market cap $256.81MP/E –Yield –

Alector free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Alector's free cash flow for the twelve months ending Jun 30, 2026 was -$158.39M. For fiscal 2025 it was -$184.07M. The highest annual figure on record is $295.30M in fiscal 2021.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$184.07M–
FY2024Dec 31, 2024-$231.16M–
FY2023Dec 31, 2023-$186.54M–
FY2022Dec 31, 2022-$24.45M-108.3%
FY2021Dec 31, 2021$295.30M–
FY2020Dec 31, 2020-$171.77M–
FY2019Dec 31, 2019-$114.57M-191.2%
FY2018Dec 31, 2018$125.58M–
FY2017Dec 31, 2017-$18.57M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$34.25M–
Q1 FY2026Mar 31, 2026-$49.93M–
Q4 FY2025Dec 31, 2025-$41.69M–
Q3 FY2025Sep 30, 2025-$32.52M–
Q2 FY2025Jun 30, 2025-$49.06M–
Q1 FY2025Mar 31, 2025-$60.80M–
Q4 FY2024Dec 31, 2024-$55.20M–
Q3 FY2024Sep 30, 2024-$50.95M–
Q2 FY2024Jun 30, 2024-$63.13M–
Q1 FY2024Mar 31, 2024-$61.88M–
Q4 FY2023Dec 31, 2023-$46.30M–
Q3 FY2023Sep 30, 2023-$46.45M–
Q2 FY2023Jun 30, 2023-$44.22M–
Q1 FY2023Mar 31, 2023-$49.57M-136.9%
Q4 FY2022Dec 31, 2022-$49.69M–
Q3 FY2022Sep 30, 2022-$50.97M-111.5%
Q2 FY2022Jun 30, 2022-$58.19M–
Q1 FY2022Mar 31, 2022$134.40M–
Q4 FY2021Dec 31, 2021-$49.82M–
Q3 FY2021Sep 30, 2021$444.14M–
Q2 FY2021Jun 30, 2021-$45.37M–
Q1 FY2021Mar 31, 2021-$53.64M–
Q4 FY2020Dec 31, 2020-$48.45M–
Q3 FY2020Sep 30, 2020-$41.20M–
Q2 FY2020Jun 30, 2020-$46.24M–
Q1 FY2020Mar 31, 2020-$35.88M–
Q4 FY2019Dec 31, 2019-$30.40M–
Q3 FY2019Sep 30, 2019-$31.16M–
Q2 FY2019Jun 30, 2019-$27.42M–
Q1 FY2019Mar 31, 2019-$25.60M-113.9%
Q4 FY2018Dec 31, 2018-$18.07M–
Q3 FY2018Sep 30, 2018-$22.52M–
Q2 FY2018Jun 30, 2018-$17.75M–
Q1 FY2018Mar 31, 2018$183.91M–

More Alector figures

See a number that looks wrong?